BioNTech SE is currently sponsoring a Phase II clinical study titled A Phase II, Multisite, Open-label, Single Arm Trial of BNT327 in Combination With Docetaxel in Second-line Stage IV Non-small Cell ...

TORONTO, Aug. 22, 2025 /CNW/ - With thousands of press releases published each week, it can be difficult to keep up with ...

The payoff in lives and hospital time saved runs at about 100 to 1 per dollar invested, which is a great deal by any standard ...

New data from the Kentucky Cabinet for Health and Family Services shows cases of the virus have jumped significantly in the ...

The immune system’s role is usually seen as wiping out invading pathogens like bacteria and viruses, but several types of ...

Since COVID, there've been growing initiatives in Africa to start producing vaccines and medicines locally, thus gaining greater independence from global supply chains. But are these schemes ...

The Emeryville, California-based biotech has just released topline results from a phase 1/2 head-to-head study comparing its ...

The NHS has announced that it will fast-track patients with advanced head and neck cancers in England into a clinical trial of an investigational cancer vaccine. Over 100 patients will be matched to ...

Kennedy Jr., a vaccine sceptic, announced Aug. 5 that his agency will cancel nearly $500 million in funding for mRNA ...

As a summer COVID-19 surge hits Michigan, unanswered questions abound about eligibility, insurance coverage and when new ...

“This usual chain of decisions … has been disrupted. And without clarity and coordination, millions may not be able to have ...